DNLI - Denali Therapeutics Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$34.50
DETAILS
HIGH:
$40.00
LOW:
$25.00
MEDIAN:
$36.00
CONSENSUS:
$34.50
UPSIDE:
79.41%
Market Cap:
3.05B
Volume:
942,634
Avg Volume:
1,797,831
52 Week Range:
12.02-23.77
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.10
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
443
IPO Date:
2017-12-08